Overexpression of S100A4 in human cancer cell lines resistant to methotrexate

BACKGROUND: Methotrexate is a chemotherapeutic drug that is used in therapy of a wide variety of cancers. The efficiency of treatment with this drug is compromised by the appearance of resistance. Combination treatments of MTX with other drugs that could modulate the expression of genes involved in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mencía, Nuria, Selga, Elisabet, Rico, Isabel, de Almagro, M Cristina, Villalobos, Xenia, Ramirez, Sara, Adan, Jaume, Hernández, Jose L, Noé, Véronique, Ciudad, Carlos J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903526/
https://www.ncbi.nlm.nih.gov/pubmed/20515499
http://dx.doi.org/10.1186/1471-2407-10-250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903526/
https://www.ncbi.nlm.nih.gov/pubmed/20515499
http://dx.doi.org/10.1186/1471-2407-10-250

Ejemplares similares